Antiviral drugs

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

( R )-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, a vitamin E analog, is a mushroom tyrosinase inhibitor. Application ( R )-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid may be used to incorporate antioxidant property

( R )-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid, a vitamin E analog, is a mushroom tyrosinase inhibitor. Application ( R )-(+)-6-Hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid may be used to incorporate antioxidant property

(R)-1-Boc-3-pyrrolidinecarboxylic acid

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

Application ( R )-TolBINAP Pd G4 is a fourth generation (G4) Buchwald precatalyst that is similar to the third generation (G3) precatalysts&lt/A except that the amino group on the biphenyl backbone is methylated. This modification helps to prevent

Application ( R , R )-SINpEt&#8901HBF 4 is a chiral NHC ligand developed in the Glorius Lab for use in Ru(II) catalyzed enantioselective hydrogenations. It has been employed for the regioselectivity asymmetric hydrogenation of quinoxalines,

Application ( R , R )-SINpEt&#8901HBF 4 is a chiral NHC ligand developed in the Glorius Lab for use in Ru(II) catalyzed enantioselective hydrogenations. It has been employed for the regioselectivity asymmetric hydrogenation of quinoxalines,

Application Protein degrader building block ( S , R , S )-VL285 Phenol-C 3 -piperazine hydrochloride enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate

Application Protein degrader building block ( S , R , S )-VL285 Phenol-PEG 1 -piperazine hydrochloride enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology . This conjugate